5911-65-9Relevant articles and documents
GLUCOSE METABOLISM MODULATING COMPOUNDS
-
, (2016/11/14)
The present invention provides, inter alia, dihydropyridone compounds and compositions, including analogs of a vesicular monoamine transporter type 2 (VMAT2) antagonist. The present invention also provides methods of using such compounds/analogs for modulating glucose levels, and/or preventing, treating, or ameliorating the effects of diabetes and hyperglycemia.
Novel hypoglycemic dihydropyridones serendipitously discovered from O- versus C-alkylation in the synthesis of VMAT2 antagonists
Xie, Yuli,Raffo, Anthony,Ichise, Masanori,Deng, Shixian,Harris, Paul E.,Landry, Donald W.
scheme or table, p. 5111 - 5114 (2009/07/18)
Vesicular monoamine transporter type 2 (VMAT2) is a newly emerging target for both diagnostic and therapeutic applications in diabetes mellitus. In pursuit of novel VMAT2 antagonists, we identified a potent hypoglycemic agent with a novel dihydropyridone
A NEW SYNTHETIC METHOD OF NITROGEN HETEROCYCLES THROUGH A NOVEL ANNULATION
Shono, Tatsuya,Sasaki, Manji,Nagami, Kimihiko,Hamaguchi, Hiroshi
, p. 97 - 98 (2007/10/02)
A new zinc promoted coupling reaction of iminium salts with alkyl halides gave a variety of nitrogen heterocycles through a novel annulation process.